Friday, August 7, 2026 Login
Breaking
MCX, HDFC Bank, Lenskart: Chris Wood rejigs India portfolio | Markets News Amelia Kerr stars as MI London edge Spirit to snap winless run Severe COVID-19 reactivates dormant viruses and may leave a lasting viral signature After Saoji mutton jibe, Maharashtra food safety chief warned by government Access Denied
Health

Ebola Response Turns to Merck Vaccine, Gilead Drug as Congo Outbreak Worsens – Bloomberg.com

By cpstestersofficial@gmail.com · August 7, 2026 · 1 min read

  1. Ebola Response Turns to Merck Vaccine, Gilead Drug as Congo Outbreak Worsens  Bloomberg.com
  2. Moderna begins first human trial of Bundibugyo Ebola vaccine  The Hindu
  3. Treatment trials for Ebola strain behind Congo outbreak show promise, WHO says  ET HealthWorld
  4. Canada Approves Clinical Trials Of Moderna’s Ebola Vaccine  NDTV
  5. Moderna stock: Ebola Phase 1 trial signals platform expansion, not near-term revenue  Investing.com

Source link

Facebook X / Twitter WhatsApp

Related Stories

Leave a Comment

Your email address will not be published. Required fields are marked *